Current Vascular Pharmacology
Title:Editorial: The Interplay between TSH and Lipids. What Should Clinicians Know?
Volume: 13 Issue: 1
Author(s): Panagiotis Anagnostis, Spyridon N. Karras, Niki Katsiki, Vasilios G Athyros and Asterios Karagiannis
Affiliation:
Export Options
About this article
Cite this article as:
Anagnostis Panagiotis, Karras N. Spyridon, Katsiki Niki, Athyros G Vasilios and Karagiannis Asterios, Editorial: The Interplay between TSH and Lipids. What Should Clinicians Know?, Current Vascular Pharmacology 2015; 13 (1) . https://dx.doi.org/10.2174/1570161112999140305095050
DOI https://dx.doi.org/10.2174/1570161112999140305095050 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Memory Impairment is Associated with Serum Methylarginines in Older Adults
Current Alzheimer Research Current Research Issues in the Pharmacokinetics of Antiretroviral Drugs in Children
Current Pediatric Reviews Nitric Oxide, Peroxynitrite, Peroxynitrous Acid, Nitroxyl, Nitrogen Dioxide, Nitrous Oxide: Biochemical Mechanisms and Bioaction
Current Bioactive Compounds Nonalcoholic Fatty Liver Disease and Cardiovascular Disease
Current Pharmaceutical Design Increased Risk of Cardiovascular Complications in Chronic Kidney Disease: A Possible Role of Leptin
Current Pharmaceutical Design Mast Cells and Inflammatory Heart Disease: Potential Drug Targets
Cardiovascular & Hematological Disorders-Drug Targets Endothelial Dysfunction in Heart Failure: Mechanisms and Therapeutic Approaches
Current Vascular Pharmacology Biological Abilities of Rice Bran-Derived Antioxidant Phytochemicals for Medical Therapy
Current Topics in Medicinal Chemistry Stem Cell Based Tissue Engineering and Regenerative Medicine: A Review Focusing on Adult Stem Cells
Current Tissue Engineering (Discontinued) Effectiveness and Safety of Digoxin on Chronic Heart Failure
Current Pharmaceutical Analysis Editorial
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Importance of Integrating SNP and Cheminformatics Resources to Pharmacogenomics
Current Drug Metabolism GSK3 Inhibitors and Disease
Mini-Reviews in Medicinal Chemistry Ivabradine: The Hope for a Good Treatment of Ischemic Heart Disease
Current Medicinal Chemistry Hypertension in Obstructive Sleep Apnoea
Vascular Disease Prevention (Discontinued) Ascorbic Acid and Gene Expression: Another Example of Regulation of Gene Expression by Small Molecules?
Current Genomics Modulation of Cardiovascular Function by Adipokines
Cardiovascular & Hematological Disorders-Drug Targets Effect of Immunoglobulin Therapy on Blood Viscosity and potential concerns of Thromboembolism, Especially in Patients with Acute Kawasaki Disease
Recent Patents on Cardiovascular Drug Discovery Exercise and Cardiovascular Disease
Cardiovascular & Hematological Disorders-Drug Targets Virtual Screening for Cholesterol Absorption Inhibitors
Medicinal Chemistry